razoxane has been researched along with Acute Disease in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 5 (38.46) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boudíková, A; Dabrowská, L; Geršl, V; Kolář, F; Mandíková, P; Mikšík, I; Mráz, J; Neckář, J; Popelová, O; Stěrba, M | 1 |
| Trnĕný, M | 1 |
| Benesová, V; Boudová, L; Cahová, S; Dvoráková, D; Fisar, J; Holub, M; Lemez, P; Maresová, J; Slavícek, L; Stejskal, J; Svítil, P; Vásová, I | 1 |
| Csóka, M; Erdélyi, D; Erlaky, H; Horváth, E; Jókúti, L; Kovács, GT; Müller, J; Szabolcs, J; Tóth, K | 1 |
| Chauvenet, A; Constine, LS; De Alarcon, PA; Friedman, D; London, WB; Mendenhall, NP; Schwartz, CL; Sposto, R; Tebbi, CK; Villaluna, D | 1 |
| Lemez, P; Maresová, J | 1 |
| Guo, Y; Xie, X; Xue, Y | 1 |
| Lemez, P | 1 |
| Budman, DR; Calabro, A; Kreis, W | 1 |
| Comelli, A; Massimo, L | 1 |
| Krepler, P; Pawlowsky, J | 1 |
| Cassell, PG; Evans, M; Hagger, D; Haworth, C; Kanfer, EJ; Price, CM; Shepherd, J; Topham, C | 1 |
| Kamen, B; Krischer, JP; Vats, T | 1 |
4 trial(s) available for razoxane and Acute Disease
| Article | Year |
|---|---|
[Dexrazoxane in patients with B-lymphomas or acute leukemias in the 2nd complete remission enables further therapy with cardiotoxic anthracyclines over recommended cumulative doses].
Topics: Acute Disease; Adult; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Cardiotonic Agents; Female; Heart; Humans; Leukemia, Myeloid; Lymphoma, B-Cell; Male; Middle Aged; Razoxane; Recurrence; Remission Induction | 2004 |
Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease.
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chelating Agents; Cohort Studies; Enzyme Inhibitors; Female; Follow-Up Studies; Heart Diseases; Hodgkin Disease; Humans; Incidence; Leukemia, Myeloid; Lung Diseases; Male; Myelodysplastic Syndromes; Neoplasm Staging; Neoplasms, Second Primary; Osteosarcoma; Razoxane; Risk Assessment; Risk Factors; Thyroid Neoplasms; Time Factors; Topoisomerase II Inhibitors | 2007 |
Clinical trials with bis-dioxopiperazine propane (ICRF 159; NSC 129, 943) in acute leukaemias.
Topics: Acute Disease; Antineoplastic Agents; Child; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Leukemia; Piperazines; Razoxane | 1975 |
Phase II trial of ICRF-187 in children with solid tumors and acute leukemia.
Topics: Acute Disease; Adolescent; Child; Drug Evaluation; Humans; Leukemia; Neoplasms; Razoxane | 1991 |
9 other study(ies) available for razoxane and Acute Disease
| Article | Year |
|---|---|
Protective effects of dexrazoxane against acute ischaemia/reperfusion injury of rat hearts.
Topics: Acute Disease; Animals; Arrhythmias, Cardiac; Cardiovascular Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Electrocardiography; In Vitro Techniques; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Perfusion; Rats; Rats, Wistar; Razoxane; Reactive Oxygen Species; Treatment Outcome | 2012 |
[Dexrazoxane and cardiotoxicity in repeatedly treated patients].
Topics: Acute Disease; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Cardiotonic Agents; Heart; Humans; Leukemia, Myeloid; Lymphoma, B-Cell; Razoxane; Recurrence | 2004 |
Subacute cardiotoxicity caused by anthracycline therapy in children: can dexrazoxane prevent this effect?
Topics: Acute Disease; Anthracyclines; Cardiomyopathy, Dilated; Cardiovascular Agents; Child; Female; Heart; Humans; Male; Razoxane; Risk Factors | 2007 |
Protective effects of cardioxane against anthracycline-induced cardiotoxicity in relapsed acute myeloid leukemias.
Topics: Acute Disease; Antibiotics, Antineoplastic; Antineoplastic Agents; Cardiovascular Agents; Cytarabine; Daunorubicin; Female; Heart; Humans; Leukemia, Myeloid; Male; Middle Aged; Razoxane; Recurrence | 1996 |
Translocation t(7;11)(P15;P15) in a patient with therapy-related acute myeloid leukemia following bimolane and ICRF-154 treatment for psoriasis.
Topics: Acute Disease; Adult; Antineoplastic Agents; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 7; Humans; Karyotyping; Leukemia, Myeloid; Male; Neoplasms, Second Primary; Psoriasis; Razoxane; Translocation, Genetic | 1997 |
Delayed administration of dexrazoxane provides cardioprotection against anthracyclines in breast cancer or acute myeloid leukemia.
Topics: Acute Disease; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Heart; Humans; Leukemia, Myeloid; Middle Aged; Razoxane | 1997 |
In vitro effects of dexrazoxane (Zinecard) and classical acute leukemia therapy: time to consider expanded clinical trials?
Topics: Acute Disease; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Cell Death; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Humans; Inhibitory Concentration 50; Leukemia; Mitoxantrone; Razoxane; Tumor Cells, Cultured | 2001 |
[New drugs for the therapy of acute leukemia].
Topics: Acute Disease; Antineoplastic Agents; Azacitidine; Cytarabine; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Guanazole; Humans; Leukemia; Lomustine; Peptichemio; Podophyllotoxin; Razoxane; Zinostatin | 1975 |
Sister chromatid exchange (SCE) frequency in lymphocytes of patients with colorectal carcinoma treated with razoxane.
Topics: Acute Disease; Cell Cycle; Colorectal Neoplasms; Follow-Up Studies; Humans; Leukemia, Myeloid; Lymphocytes; Razoxane; Sister Chromatid Exchange | 1992 |